Minerva Deferred Long Term Liab from 2010 to 2024
| NERV Stock | USD 2.26 0.00 0.00% |
Deferred Long Term Liabilities | First Reported 2014-06-30 | Previous Quarter 15.2 M | Current Value 15.2 M | Quarterly Volatility 14.3 M |
Check Minerva Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva Neurosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 29.4 K, Interest Expense of 8.7 M or Selling General Administrative of 10.9 B, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Minerva financial statements analysis is a perfect complement when working with Minerva Neurosciences Valuation or Volatility modules.
Minerva | Deferred Long Term Liab |
Latest Minerva Neurosciences' Deferred Long Term Liab Growth Pattern
Below is the plot of the Deferred Long Term Liab of Minerva Neurosciences over the last few years. It is liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue. Minerva Neurosciences' Deferred Long Term Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Minerva Neurosciences' overall financial position and show how it may be relating to other accounts over time.
| Deferred Long Term Liab | 10 Years Trend |
|
Deferred Long Term Liab |
| Timeline |
Minerva Deferred Long Term Liab Regression Statistics
| Arithmetic Mean | 11,631,430 | |
| Geometric Mean | 6,299,530 | |
| Coefficient Of Variation | 110.28 | |
| Mean Deviation | 8,931,228 | |
| Median | 13,433,760 | |
| Standard Deviation | 12,827,422 | |
| Sample Variance | 164.5T | |
| Range | 43.7M | |
| R-Value | (0.46) | |
| Mean Square Error | 140T | |
| R-Squared | 0.21 | |
| Significance | 0.09 | |
| Slope | (1,313,722) | |
| Total Sum of Squares | 2303.6T |
Minerva Deferred Long Term Liab History
About Minerva Neurosciences Financial Statements
Minerva Neurosciences investors use historical fundamental indicators, such as Minerva Neurosciences' Deferred Long Term Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Minerva Neurosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Deferred Long Term Liabilities | 1.6 M | 1.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.